Pfizer is developing rare lung cancer drug

September 28, 2014 1:35 PM

5 0

Pfizer is developing rare lung cancer drug

A lung cancer drug made by a pharmaceutical company, Pfizer Inc is showing positive results against rare genetic mutation in the ROS1 gene, according to a report presented by Pfizer at medical meeting, on Saturday. The company is using all of its resources in getting the drug approved by the Food and Drug Department.

For testing, the drug Pfizer included 50 non-small cell lung cancer patients having rearrangement of ROS1 gene. After treating them with the drug, the tumor got shrunk in 36 patients and in nine patients it stopped growing. The drug behaved remarkably well against the disease; even Pfizer was astoni...

Read more

To category page